Ilmarinen Mutual Pension Insurance Co Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ilmarinen Mutual Pension Insurance Co lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 40.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,000 shares of the medical equipment provider’s stock after purchasing an additional 9,000 shares during the period. Ilmarinen Mutual Pension Insurance Co’s holdings in Intuitive Surgical were worth $7,920,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of ISRG. MONECO Advisors LLC increased its position in shares of Intuitive Surgical by 3.5% during the first quarter. MONECO Advisors LLC now owns 964 shares of the medical equipment provider’s stock worth $246,000 after purchasing an additional 33 shares in the last quarter. Patron Partners LLC increased its position in shares of Intuitive Surgical by 2.3% during the first quarter. Patron Partners LLC now owns 1,481 shares of the medical equipment provider’s stock worth $378,000 after purchasing an additional 34 shares in the last quarter. Forum Financial Management LP increased its position in shares of Intuitive Surgical by 1.9% during the first quarter. Forum Financial Management LP now owns 1,927 shares of the medical equipment provider’s stock worth $492,000 after purchasing an additional 36 shares in the last quarter. Arlington Partners LLC increased its position in shares of Intuitive Surgical by 14.3% during the first quarter. Arlington Partners LLC now owns 288 shares of the medical equipment provider’s stock worth $74,000 after purchasing an additional 36 shares in the last quarter. Finally, Covenant Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% during the first quarter. Covenant Asset Management LLC now owns 2,057 shares of the medical equipment provider’s stock worth $526,000 after purchasing an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 82.91% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $310.00, for a total transaction of $620,000.00. Following the sale, the director now owns 25,319 shares in the company, valued at approximately $7,848,890. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $310.00, for a total transaction of $620,000.00. Following the sale, the director now owns 25,319 shares in the company, valued at approximately $7,848,890. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 50,314 shares of the company’s stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $326.76, for a total value of $16,440,602.64. Following the sale, the chief executive officer now owns 17,186 shares in the company, valued at approximately $5,615,697.36. The disclosure for this sale can be found here. Insiders have sold a total of 59,809 shares of company stock worth $19,496,481 in the last quarter. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on ISRG shares. Wells Fargo & Company boosted their price target on Intuitive Surgical from $310.00 to $386.00 and gave the stock an “overweight” rating in a research report on Friday, July 21st. Citigroup boosted their price objective on Intuitive Surgical from $317.00 to $400.00 in a research note on Monday, July 10th. Piper Sandler boosted their price objective on Intuitive Surgical from $315.00 to $385.00 and gave the stock an “overweight” rating in a research note on Friday, July 21st. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $335.00 to $365.00 and gave the stock an “overweight” rating in a research note on Friday, July 21st. Finally, Barclays boosted their price objective on Intuitive Surgical from $314.00 to $385.00 and gave the stock an “overweight” rating in a research note on Monday, July 24th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $343.10.

View Our Latest Report on ISRG

Intuitive Surgical Trading Down 0.3 %

ISRG stock opened at $301.55 on Wednesday. The company has a market capitalization of $105.96 billion, a PE ratio of 75.58, a P/E/G ratio of 4.22 and a beta of 1.30. Intuitive Surgical, Inc. has a 12-month low of $180.07 and a 12-month high of $358.07. The business’s fifty day moving average price is $316.43 and its 200 day moving average price is $296.56.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. Intuitive Surgical had a return on equity of 12.41% and a net margin of 21.38%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the business earned $0.85 EPS. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 4.48 EPS for the current fiscal year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.